Skip to content
Pipeline
Bipolar Disorder: OAK-0011379
Geriatric Psychosis: OAK-0011799
Our Science
Partners & Investors
About Us
Meet Our Team
News & Publications
Contact Us
Nimh Award
Blue Oak awarded a $2.9M Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Mental Health (NIMH) to develop next generation drugs for bipolar disorder
Pipeline
Bipolar Disorder: OAK-0011379
Geriatric Psychosis: OAK-0011799
Our Science
Partners & Investors
About Us
Meet Our Team
News & Publications
Contact Us
caret-down
close
facebook-square
hamburger
instagram-square
linkedin-square
pause
play
twitter-square